Skip to main content Accessibility help
×
Home
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 1
  • Print publication year: 2012
  • Online publication date: November 2012

6 - Toxicology of dendrimers and dendrons

Summary

Introduction

Interest in pharmaceuticals, especially their benefits to human health and toxicology has a long history. Although the earliest activities were oriented toward benefits to health, it is also well known that there was substantial interest in the toxicology aspects of this field. As early as Roman times there was considerable political interest in design of certain potions as effective poisons for shortening life. Subsequent to this early history, legitimate pharmaceutical activities focused on preservation, remediation, and extension of life. These activities emerged in Europe as early as the twelfth century. One of the first pharmacies established in 1241 is still operational in Trier, Germany.

The pharmaceutical industry in the United States is much younger and its origins can be traced to the Philadelphia area. More than a half dozen fine chemical manufacturers founded as early as 1822 are still in existence today. This activity launched the beginning of the modern pharmaceutical industry as we know it. This movement manifested a shift from manufacturing of medicines in pharmacy laboratories to formal construction of manufacturing plants for this purpose. Throughout this period, drug reactions and benefits were documented as doctors and pharmacists compounded and administered medicines to patients.

Concurrent with the growth of this industry was an explosive growth and expansion of traditional small molecule chemistry. This parallel development of traditional chemistry led to the introduction of many small molecule inorganic/ organic therapies. Some of these therapies were beneficial while others were harmful to society and the industry. These early pharmaceutical candidates were both synthetic and natural in origin. They became the scientific platform and basis for the commercial activity of essentially all major pharmaceutical companies worldwide.

Related content

Powered by UNSILO
References
Swann, J.P. 2004 http://www.fda.gov/oc/history/historyoffda/fulltext.html
Bawa, R.Melethil, S.Simmons, W. J.Harris, D.The SciTech Lawyer 5 2008
Nel, A.Xia, T.Mädler, L.Li, N.Science 311 2006 622
Oberdörster, G.Oberdörster, E.Oberdörster, J.Environ. Health Perspect 113 2005 823
Mosmann, T.J. Immunol. Meth 65 1983 55
Wroblewski, F.La Due, J. S.Proc. Soc. Exp. Biol. Med 90 1955 210
Mortimer, M.Kasemets, K.Heinlaan, M.Kurvet, I.Kahru, A.Toxicology in Vitro 22 2008 1412
Hong, S.Bielinska, A.U.Mecke, A.Bioconjugate Chem 15 2004 774
Karoonuthaisiri, N.Titiyevskiy, K.Thomas, J.L.Colloids and Surfaces B., Biointerfaces 27 2003 365
Neerman, M.F.Zhang, W.Parrish, A.R.Simanek, E.E.Int. J. Pharm 281 2004 129
Brazeau, G.A.Attia, S.Poxon, S.Hughes, J.A.Pharmacol. Res 15 1998 680
Bourne, N.Stanberry, L.R.Kern, E.R.Antimicrob. Agents Chemother 44 2000 2471
Malik, N.Wiwattanapatapee, R.Klopsch, R.J. Controlled Release 65 2000 133
Chen, H.-T.Neerman, M.F.Parrish, A.R.Simanek, E.E.J. Am. Chem. Soc. 126 2004 10044
Cordes, H.Boas, U.Olsen, P.Heegaard, P.M.H.Biomacromolecules 8 2007 3578
Nam, H.Y.Hahn, H.J.Nam, K.Int. J. Pharm 363 2008 199
Chung, H-H.Harms, G.Seong, C.M.Biopolymers 76 2004 83
Jevprasesphant, R.Penny, J.Jalal, R.Int. J. Pharm 252 2003 263
Shah, D.S.Sakthievel, T.Toth, I.Florence, A. T.Wilderspin, A.F.Int. J. Pharm 208 2000 41
Fuchs, S.Kapp, T.Otto, H.Chem. Eur. J 10 2004 1167
Heiden, T.C.K.Dengler, E.Kao, W.J.Heideman, W.Peterson, R.E.Toxicol. Applied Pharmacol 225 2007 70
El-Sayed, M.Ginski, M.Rhodes, C.A.Ghandehari, H.J. Bioactive Compat. Polym 18 2003 7
Higashiyama, S.Noda, M.Kawase, M.Yagi, K.J. Biomed. Mater. Res 64A 2003 475
de Jesus, O.L. PadillaIhre, H.R.Gagne, L.Fréchet, J.M.Szoka, F.C.Bioconjugate Chem 13 2002 453
Haensler, J.Szoka, F.C.Bioconjugate Chem 4 1993 472
Zinselmeyer, B.H.Mackay, S.P.Schatzlein, A.G.Uchegbu, I.F.Pharmacol. Res 19 2002 960
Fischer, D.Li, Y.Ahlemeyer, B.Krieglstein, J.Kissel, T.Biomaterials 24 2003 1121
Zhang, X.-Q.Wang, X.-L.Huang, S.-W.Biomacromolecules 6 2005 341
Domański, D.M.Klajnert Bryszewska, B.Bioelectrochemistry 63 2004 189
Tang, M.X.Redemann, C.T.Szoka, F.C.Bioconjugate Chem 7 1996 703
Tang, M.X.Szoka, F.C.Gene Ther 4 1997 823
Krishna, T.R.Jayaraman, N.J. Org. Chem 68 2003 9694
Krishna, T.R.Jain, S.Tatu, U.S.Jayaraman, N.Tetrahedron 61 2005 4281
Ihre, H.R.Jesus, O.L. Padilla DeSzoka, F.C.Fréchet, J.M.Bioconjugate Chem 13 2002 443
Ferutti, P.Knobloch, S.Ranucci, E.Gianasi, E.Duncan, R.Proc. Int. Symp. Controlled Rel. Bioact. Mater 1997 45
Ferruti, P.Knobloch, S.Ranucci, E.Duncan, R.Gianasi, E.Macromol. Chem. Phys 199 1998 2565
Hong, S.Bielinska, A.U.Mecke, A.Bioconjugate Chem 15 2004 774
Kolhatkar, R.B.Kitchens, K.M.Swaan, P.W.Ghandehari, H.Bioconjugate Chem 18 2007 2054
Wang, W.Xiong, W.Wan, J.Nanotechnology 20 2009
Kuo, J.H.Jan, M.S.Chiu, H.W.J. Pharm. Pharmacol 57 2005 489
Kuo, J.H.Jan, M.S.Lin, Y.L.J. Control. Release 120 2007 51
Yoo, H.Juliano, R.L.Nucleic Acid Res 28 2000 4225
Rajananthanan, P.Attard, G.S.Sheikh, N.A.Morrow, W.J.Vaccine 17 1999 715
Gössi, I.Shu, L.Schlüter, A.D.Rabe, J.P.J. Am. Chem. Soc 124 2002 6860
Gebhart, C.L.Kabanov, A.V.J. Controlled Release 73 2001 401
Andrews, J.M.Newbound, G.C.Lairmore, M.D.Nucleic Acid Res. 25 1997 1082
Männistö, M.Vanderkerken, S.Toncheva, V.J. Controlled Release 83 2002 169
Margerum, L.D.Campion, B.K.Koo, M.J. Alloys Compounds 249 1997 185
Santana, A.Hyslop, S.Antunes, E.Agents Actions 39 1993 104
Roberts, J.C.Bhalgat, M.K.Zera, R.T.J. Biomed. Mater. Res 30 1996 53
Jevprasesphant, R.Penny, J.Attwood, D.McKeown, N.B.D’Emmanuele, A.D.Pharm. Res 20 2003 1543
Kobayashi, H.Sato, N.Kawamoto, S.Bioconjugate Chem 12 2001 100
Kobayashi, H.Kawamoto, S.Saga, T.Magn. Res. Med 46 2001 781
Tomalia, D.A.Reyna, L. A.Svenson, S.Biochem. Soc. Trans. 35 2007 61
Sakthivel, T.Toth, I.Florence, A.T.Int. J. Pharm. 183 1999 51
Nigavakar, S.S.Sung, L.Y.Llanes, M.Pharm. Res 21 2004 476
Plank, C.Mechtler, K.Szoka, F.C.Wagner, E.Human Gene Ther 7 1996 1437
Shaunak, S.Thomas, S.Gianasi, E.Nature Biotechnology 22 2004 977
Chauhan, A.S.Diwah, P.VJain, N.K.Tomalia, D.A.Biomacromolecules 10 2009 1195
Toyama, T.Matsuda, H.Ishida, I.Contact Dermatitis 59 2008 122